Literature DB >> 34258902

COVID-19 and cardiovascular system-a comprehensive review.

Ibrahim AlShahrani1, Jagadish Hosmani2, Vidya Gurram Shankar3, Abdulaziz AlShahrani1, Rafi Ahmad Togoo1, Syed M Yassin1, Shahrukh Khan4, Shankargouda Patil5.   

Abstract

Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate of 31% of deaths worldwide out of which nearly 85% are due to heart attacks and stroke. Theoretically and practically, researchers have observed that persons with pre-existing cardiovascular conditions are comparatively more vulnerable to the COVID-19 infection. Moreover, they have studied the data between less severe and more severe cases, survivors and non survivors, intensive care unit (ICU) patients and non ICU patients, to analyse the relationship and the influence of COVID-19 on cardiovascular health of an individual, further the risk of susceptibility to submit to the virus. This review aims to provide a comprehensive particular on the possible effects, either direct or indirect, of COVID-19 on the cardiovascular heath of an individual.
© 2021 The Author(s). Published by IMR Press.

Entities:  

Keywords:  ACE2; COVID-19; Cardiovascular disorders; Comorbidities

Year:  2021        PMID: 34258902     DOI: 10.31083/j.rcm2202041

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  5 in total

1.  Mallampati Score Is an Independent Predictor of Active Oxygen Therapy in Patients with COVID-19.

Authors:  Maciej Dyrbuś; Aleksandra Oraczewska; Szymon Szmigiel; Szymon Gawęda; Paulina Kluszczyk; Tomasz Cyzowski; Marek Jędrzejek; Paweł Dubik; Michał Kozłowski; Sebastian Kwiatek; Beata Celińska; Michał Wita; Ewa Trejnowska; Andrzej Swinarew; Tomasz Darocha; Adam Barczyk; Szymon Skoczyński
Journal:  J Clin Med       Date:  2022-05-24       Impact factor: 4.964

2.  Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing.

Authors:  Han Bai; Junpeng Ma; Weikang Mao; Xuan Zhang; Yijun Nie; Jingcan Hao; Xiaorui Wang; Hongyu Qin; Qiqi Zeng; Fang Hu; Xin Qi; Xiaobei Chen; Dong Li; Binghong Zhang; Bingyin Shi; Chengsheng Zhang
Journal:  Blood Cells Mol Dis       Date:  2022-06-02       Impact factor: 2.372

3.  Laboratory medicine in pandemic of COVID-19.

Authors:  Leida Tandara; Petra Filipi; Daniela Supe Domic; Branka Kresic; Ivo Ivcic; Sanda Stojanovic Stipic; Zana Rubic; Marijan Tandara
Journal:  Biochem Med (Zagreb)       Date:  2022-04-15       Impact factor: 2.313

Review 4.  A review on therapeutical potential of paeonol in atherosclerosis.

Authors:  Wei Yu; Iqra Ilyas; Nasrin Aktar; Suowen Xu
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

5.  Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.

Authors:  Ioannis Pantazopoulos; Georgios Mavrovounis; Georgios Dimeas; Nikolaos Zikos; Maria Pitsikou; Eleni Rousogianni; Maria Mermiri; Anastasia Michou; Michalis Spanos; Christos Maniotis; Athanasios Chalkias; Eleni Laou; Georgios Zakynthinos; Dimitrios Chatzis; Konstantinos Gourgoulianis
Journal:  Am J Cardiovasc Drugs       Date:  2022-08-25       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.